Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Lapharmaca AB
AB
Active
Org 5594921727
Fyrspannsgatan 164-166
Retail sale of pharmaceutical products · NACE 4773
Est. 2024
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 10,9M
EBITDA margin
17.0%
Equity ratio
12.5%
Financial strength
Net profit 2025
SEK 1,1M
EBITDA — year on year
SEK millions
3M
2M
1M
1M
0M
2M
2025
Key figures
Annual report 2025
Revenue
SEK 10,9M
—
EBITDA
SEK 1,9M
—
Net profit
SEK 1,1M
—
Total assets
SEK 8,8M
—
Equity
SEK 1,1M
—
Employees
—
—
Company information
Legal name
Lapharmaca AB
Org number
5594921727
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
7 augusti 2024
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva apoteks- och hälsokostverksamhet och därmed sammanhörande verksamheter.
Contact
Address
Fyrspannsgatan 164-166
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Retail sale of pharmaceutical products
Companies in Stockholm
All Sweden companies
Revenue
SEK millions
0M
3M
6M
9M
13M
11M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
2M
2025
Income statement
SEK thousands
Item
2025
Revenue
10 875
Staff expenses
−828
EBITDA
1 852
Depreciation & amort.
−51
EBIT
1 801
Net financials
0
Profit before tax
1 351
Tax
−279
Net profit
1 072
Balance sheet
SEK thousands
Item
2025
Total assets
8 787
Equity
1 097
Long-term debt
—
Short-term debt
7 240
Total debt
7 240
Financial ratios
5-year trend
EBITDA margin
17.0%
This company
15.8%
Market median
+8% vs market
2025
2025
Equity ratio
12.5%
This company
38.2%
Market median
-67% vs market
2025
2025
Return on equity
97.7%
This company
18.4%
Market median
+431% vs market
2025
2025
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
2025
2025
Asset turnover
1.24×
This company
1.12×
Market median
+11% vs market
2025
2025
Debt / equity
7.01×
This company
0.62×
Market median
-1031% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-08-07 – 2025-04-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LT
Lana Toffik Arif
Board of Directors
2024
JH
Jazia Hajo
Deputy Board Member
2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Lapharmaca AB also hold positions in
0
other companies.
Person
Role here
Other companies
Lana Toffik Arif
Board of Directors
0 companies
Jazia Hajo
Deputy Board Member
0 companies